The medical equipment track ushered in a wave of listings, and many companies embarked on the road to IPO

【Pharmaceutical Network Pharmaceutical Stock Market】 Since the beginning of this year, the pharmaceutical equipment track has ushered in a wave of listing, and many medical device companies have embarked on the road to IPO, such as IVD, medical equipment, medical consumables and other subdivisions of the industry have enterprises eager to try

.

Among them, the listing of Lianying Medical has increased the attention of

the entire medical device sector.

It is reported that on August 22, Lianying Medical officially landed on the Science and Technology Innovation Board, with a total fundraising of 10.988 billion yuan, surpassing mindray Medical's IPO fundraising record in 2018 (5.934 billion yuan) and becoming a large-scale medical device IPO

.

The industry said that as a hot IPO during the year, the listing of Lianying Medical has increased the attention of

the entire medical device sector.

According to the data, Lianying Medical was established in 2011, focusing

on the design, research and development and production of high-end medical imaging diagnostic products, radiation therapy products and high-end life science instruments.

According to the prospectus, Lianying Medical has established a high-end medical equipment product line

.

As of the end of the reporting period, United Pictures Medical has launched more than 80 products to the market, including MR (Magnetic Resonance Imaging System), CT (X-Camera Computed Tomography System), XR (X-ray Imaging System), PET/CT/, PET/MR (Molecular Imaging System), RT (Medical Linear Accelerator System) and life science instruments

.

In addition to Lianying Medical, there are also a number of medical device companies on the road to

IPO.

For example, on June 29, Mingfeng Medical's application for listing to the Science and Technology Innovation Board was accepted, with the status of "Inquired", which is a major progress
in the company's application for listing since its establishment 11 years ago.

According to public information, Mingfeng Medical focuses on high-end medical imaging equipment, and its main products and services include the sales and after-sales maintenance services of large-scale medical imaging equipment such as CT and PET/CT, of which the company has listed 18 CT products and 3 PET/CT products
.

It is reported that Mingfeng Medical has always attached importance to independent innovation and research and development since its inception, and its CT product line can be called the "business card"
of Mingfeng Medical.

It mainly includes 8 rows, 16 rows, 24 rows, 48 rows, 64 rows, 256 rows, vehicle CT series, Ark CT series, etc.
, covering clinical practical popularization models to ultra-high-end scientific research models and mobile medical equipment
.

In addition, a number of medical imaging companies such as Neusoft Medical have also submitted IPO applications
.

For example, Neusoft Medical is a medical imaging solution provider whose four major businesses include digital diagnosis and treatment equipment, in vitro diagnostic equipment and reagents, MDaaS solutions and equipment services and training
.

According to the data, from 2018 to 2020, Neusoft Medical's revenue was 1.912 billion yuan, 1.907 billion yuan and 2.459 billion yuan, and profits were 169 million yuan, 82 million yuan and 92.8 million yuan, respectively.

R&D expenditure accounted for 20.9%, 21.4% and 15.3%.
Industry insiders said that with the release of the fifth set of guidelines for the application of listing standards for medical device enterprises on the Science and Technology Innovation Board, more innovative medical device companies will land on A-shares in the future, and the overall investment value of the sector will be further highlighted
.

It is reported that on August 23, microelectronophysiology also announced the results of
the winning lottery.

According to its prospectus, the company issued 70.6 million shares in this public offering, and plans to raise 1,011.
8256 million yuan for intervention in medical device research and development projects, production base construction projects, marketing service system construction projects and supplementary working capital
.

However, the industry also pointed out that medical imaging devices also face potential "card neck" risks
.

This high-tech barrier industry involves a large number
of core components.

Taking Lianying Medical as an example, although it has achieved self-development and self-production of parts in multiple production lines, it still needs to be purchased
in CT high-end arenas, MI chips and other parts.

Disclaimer: In no event shall the information or opinions expressed herein constitute investment advice
to any person.